Who are The Cancer Letter readers?

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

After 45 years of covering oncology, we stopped and asked our readers: who are you?

In a survey sent out to The Cancer Letter’s weekly mailing list, we asked key questions about our readers, their professional degrees, their fields of interest, and their satisfaction with our coverage.

We were pleased to learn that you like us: 83.1% of you rated your satisfaction with our reporting of your areas of interest at a 4 or 5 out of 5, with an average score of 4.1 out of 5 (82%).

We sent the survey to a list of 6,000 readers, and received 419 responses (7%).

story1-1

Of the responses, 37.7% are MDs and 35.6% are PhDs. Within that list, 25 are MD PhDs (6%).

story1-2

*terminal degree

You identified yourselves primarily as clinicians (33.7%), basic scientists (27.2%), and administrators (30.3%)—a surprisingly balanced spread.

story1-3

While this survey didn’t include the thousands of readers at institutions that distribute the PDF internally, we were pleased to learn that you love reading our PDF edition as well as our online content. Redesigned in 2017, our PDF edition has won design awards, and is a primary way many of our readers access The Cancer Letter.

The Cancer Letter has over 200 institutional subscribers.
For login or subscription issues, inquiries about group rates, advertising, or any other administrative questions please contact
katie@cancerletter.com.

story1-4

story1-5

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login